452 related articles for article (PubMed ID: 25393922)
21. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901
[TBL] [Abstract][Full Text] [Related]
23. Improved Cardiomyopathy Risk Prediction Using Global Longitudinal Strain and N-Terminal-Pro-B-Type Natriuretic Peptide in Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy.
Ehrhardt MJ; Liu Q; Mulrooney DA; Rhea IB; Dixon SB; Lucas JT; Sapkota Y; Shelton K; Ness KK; Srivastava DK; McDonald A; Robison LL; Hudson MM; Yasui Y; Armstrong GT
J Clin Oncol; 2024 Apr; 42(11):1265-1277. PubMed ID: 38207238
[TBL] [Abstract][Full Text] [Related]
24. Cardiac markers (BNP, NT-pro-BNP, Troponin I, Troponin T, in female amateur runners before and up until three days after a marathon.
Frassl W; Kowoll R; Katz N; Speth M; Stangl A; Brechtel L; Joscht B; Boldt LH; Meier-Buttermilch R; Schlemmer M; Roecker L; Gunga HC
Clin Lab; 2008; 54(3-4):81-7. PubMed ID: 18630737
[TBL] [Abstract][Full Text] [Related]
25. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
26. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
[TBL] [Abstract][Full Text] [Related]
27. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise.
Scharhag J; Herrmann M; Urhausen A; Haschke M; Herrmann W; Kindermann W
Am Heart J; 2005 Dec; 150(6):1128-34. PubMed ID: 16338248
[TBL] [Abstract][Full Text] [Related]
28. Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients.
Dyer AK; Barnes AP; Fixler DE; Shah TK; Sutcliffe DL; Hashim I; Drazner MH; de Lemos JA
Am Heart J; 2012 Apr; 163(4):595-600. PubMed ID: 22520525
[TBL] [Abstract][Full Text] [Related]
29. Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer.
Goel S; Simes RJ; Beith JM
Asia Pac J Clin Oncol; 2011 Sep; 7(3):276-80. PubMed ID: 21884439
[TBL] [Abstract][Full Text] [Related]
30. Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease.
Munoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Reynaga DD; Ramirez ID; Borges AC; Wallukat G; Ziebig R; Schimke I
Clin Biochem; 2013 Oct; 46(15):1615-8. PubMed ID: 23810852
[TBL] [Abstract][Full Text] [Related]
31. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review.
Leerink JM; Verkleij SJ; Feijen EAM; Mavinkurve-Groothuis AMC; Pourier MS; Ylänen K; Tissing WJE; Louwerens M; van den Heuvel MM; van Dulmen-den Broeder E; de Vries ACH; Ronckers CM; van der Pal HJH; Kapusta L; Loonen J; Bellersen L; Pinto YM; Kremer LCM; Kok WEM
Heart; 2019 Feb; 105(3):210-216. PubMed ID: 30158136
[TBL] [Abstract][Full Text] [Related]
33. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.
Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I
J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994
[TBL] [Abstract][Full Text] [Related]
34. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
Lipshultz SE; Miller TL; Scully RE; Lipsitz SR; Rifai N; Silverman LB; Colan SD; Neuberg DS; Dahlberg SE; Henkel JM; Asselin BL; Athale UH; Clavell LA; Laverdière C; Michon B; Schorin MA; Sallan SE
J Clin Oncol; 2012 Apr; 30(10):1042-9. PubMed ID: 22370326
[TBL] [Abstract][Full Text] [Related]
35. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.
Brouwer CA; Postma A; Vonk JM; Zwart N; van den Berg MP; Bink-Boelkens MT; Dolsma WV; Smit AJ; de Vries EG; Tissing WJ; Gietema JA
Eur J Cancer; 2011 Nov; 47(16):2453-62. PubMed ID: 21696947
[TBL] [Abstract][Full Text] [Related]
36. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
[TBL] [Abstract][Full Text] [Related]
37. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
38. Medium-term assessment of cardiac function in pediatric cancer survivors. Comparison of different echocardiographic methods, cardiac MRI and cardiac biomarker testing in adolescent cancer survivors.
Shah SS; McClellan W; Knowlton JQ; Mehta J; Goudar S; Ferguson A; Sherman A; Shirali G; Fulbright J
Echocardiography; 2017 Feb; 34(2):250-256. PubMed ID: 27996161
[TBL] [Abstract][Full Text] [Related]
39. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
[TBL] [Abstract][Full Text] [Related]
40. Growth-differentiation factor-15 and tissue doppler ımaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors.
Arslan D; Cihan T; Kose D; Vatansev H; Cimen D; Koksal Y; Oran B; Akyurek F
Clin Biochem; 2013 Sep; 46(13-14):1239-43. PubMed ID: 23850849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
